author-photo

Timothy Harrison

University of Nottingham
Nottingham City Hospital
Queen's University Belfast

147

Papers

3391

Citations

Citation Trend

Filter By

Papers (110) Sort By

Journal Conference Others

OCS Reduction According to the Presence of Nasal Polyps or Atopic Status in the PONENTE Study

2021 American Journal of Respiratory and Critical Care Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study.

2021 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (2)
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.

2020 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (26)
Preventer Therapy for Mild Asthma: A Qualitative Study of Patients' Treatment Experiences

2020
Show All
- Source
- Cite
- Save
Citations (0)
Towards a personalised treatment approach for asthma attacks.

2020 Thorax
Show All
- Source
- Cite
- Save
Citations (2)
Clinical Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma and Nasal Polyposis: Pooled Analysis of the SIROCCO and CALIMA Trials

2019 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (2)
Identification and SAR exploration of a novel series of Legumain inhibitors

2019 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (2)
Email fraud: The search for psychological predictors of susceptibility

2019 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (20)
Idiopathic chronic productive cough and response to open‐label macrolide therapy: An observational study

2019 Respirology
Show All
- Source
- Cite
- Save
Citations (7)
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial

2018 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (72)